Optain is a healthcare technology company that uses AI and machine learning to detect eye and systemic conditions through retinal imaging, improving access to care. Founded in Australia in 2019, the company recently received FDA clearance for its Resolve retinal camera, closed a Series A led by Insight Partners, and is rapidly expanding across U.S. health systems.